Amena Warner

760 total citations
10 papers, 164 citations indexed

About

Amena Warner is a scholar working on Immunology and Allergy, Physiology and Immunology. According to data from OpenAlex, Amena Warner has authored 10 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology and Allergy, 3 papers in Physiology and 3 papers in Immunology. Recurrent topics in Amena Warner's work include Food Allergy and Anaphylaxis Research (7 papers), Allergic Rhinitis and Sensitization (5 papers) and Asthma and respiratory diseases (3 papers). Amena Warner is often cited by papers focused on Food Allergy and Anaphylaxis Research (7 papers), Allergic Rhinitis and Sensitization (5 papers) and Asthma and respiratory diseases (3 papers). Amena Warner collaborates with scholars based in United Kingdom, United States and Ireland. Amena Warner's co-authors include Stella Cochrane, Jan Gutermuth, Peck Y. Ong, Óscar Palomares, Jürgen Schwarze, Mübeccel Akdiş, Marek Jutel, Rebecca Knibb, André C. Knulst and Nazira Sumar and has published in prestigious journals such as PLoS ONE, Allergy and Clinical & Experimental Allergy.

In The Last Decade

Amena Warner

10 papers receiving 159 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amena Warner United Kingdom	7	93	54	38	33	33	10	164
Roxana Silvia Bumbăcea Romania	8	71 0.8×	79 1.5×	26 0.7×	16 0.5×	57 1.7×	30	188
Ayşegül Akarsu Türkiye	10	146 1.6×	59 1.1×	28 0.7×	13 0.4×	34 1.0×	24	224
C. Poreaux France	9	53 0.6×	112 2.1×	67 1.8×	45 1.4×	18 0.5×	22	189
Corrado Mirone Italy	9	158 1.7×	69 1.3×	76 2.0×	42 1.3×	131 4.0×	17	261
A. Fuat Kalyoncu Türkiye	9	119 1.3×	55 1.0×	107 2.8×	55 1.7×	139 4.2×	23	292
Chrystyna Kalicinsky Canada	5	41 0.4×	26 0.5×	43 1.1×	16 0.5×	10 0.3×	18	94
Gerda Wurpts Germany	8	87 0.9×	91 1.7×	113 3.0×	44 1.3×	20 0.6×	39	192
Alice Koehli Switzerland	5	319 3.4×	115 2.1×	91 2.4×	36 1.1×	81 2.5×	5	349
Marcel M. Bergmann Switzerland	8	227 2.4×	146 2.7×	62 1.6×	35 1.1×	63 1.9×	28	318
Adrianna Machinena Spain	8	172 1.8×	70 1.3×	20 0.5×	11 0.3×	92 2.8×	16	205

Countries citing papers authored by Amena Warner

Since Specialization

Citations

This map shows the geographic impact of Amena Warner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amena Warner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amena Warner more than expected).

Fields of papers citing papers by Amena Warner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amena Warner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amena Warner. The network helps show where Amena Warner may publish in the future.

Co-authorship network of co-authors of Amena Warner

This figure shows the co-authorship network connecting the top 25 collaborators of Amena Warner. A scholar is included among the top collaborators of Amena Warner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amena Warner. Amena Warner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Erlewyn‐Lajeunesse, Michel, Maria Elisa Smith, Thomas L. Dawson, et al.. (2025). Inequalities in Access to Specialist Allergy Services in the United Kingdom: A Report From the BSACI Registry for Immunotherapy ( BRIT ). Clinical & Experimental Allergy. 55(6). 458–468. 3 indexed citations

Jani, Yogini, Iestyn Williams, Ron Daniels, et al.. (2024). Factors influencing implementation and adoption of direct oral penicillin challenge for allergy delabelling: a qualitative evaluation. BMJ Open Quality. 13(3). e002890–e002890. 2 indexed citations

Savic, Louise, Michael R. Ardern‐Jones, Anthony Avery, et al.. (2022). BSACI guideline for the set‐up of penicillin allergy de‐labelling services by non‐allergists working in a hospital setting. Clinical & Experimental Allergy. 52(10). 1135–1141. 35 indexed citations

Tsoumani, Marina, Lynne Regent, Amena Warner, et al.. (2022). Allergy to Peanuts imPacting Emotions And Life (APPEAL): The impact of peanut allergy on children, teenagers, adults and caregivers in the UK and Ireland. PLoS ONE. 17(2). e0262851–e0262851. 12 indexed citations

Higgs, Jennette, et al.. (2021). Dissemination of EAACI food allergy guidelines using a flexible, practical, whole school allergy awareness toolkit. Allergy. 76(11). 3479–3488. 7 indexed citations

Agache, Ioana, Cezmi A. Akdiş, Mübeccel Akdiş, et al.. (2021). EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old. Allergy. 77(1). 17–38. 30 indexed citations

Agache, Ioana, Cezmi A. Akdiş, Mübeccel Akdiş, et al.. (2020). EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis. Allergy. 76(4). 988–1009. 25 indexed citations

Madsen, Charlotte Bernhard, Stella Cochrane, Geert F. Houben, et al.. (2020). Can we define a level of protection for allergic consumers that everyone can accept?. Regulatory Toxicology and Pharmacology. 117. 104751–104751. 39 indexed citations

Varney, Veronica, et al.. (2019). <p>IgE-Mediated Systemic Anaphylaxis And Its Association With Gene Polymorphisms Of ACE, Angiotensinogen And Chymase</p>. Journal of Asthma and Allergy. Volume 12. 343–361. 10 indexed citations

10.

Gardulf, Ann, et al.. (2008). The role of nurses in recognizing and caring for patients with primary immunodeficiencies. Pharmaceuticals Policy and Law. 10(1-4). 43–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact